Financials California Nanotechnologies Corp. OTC Markets
Equities
CANOF
CA1304921010
Industrial Machinery & Equipment
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.74 USD | +34.55% | +104.31% | +346.59% |
Valuation
Fiscal Period: February | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capitalization 1 | 1.432 | 1.055 | 3.821 | 1.985 | 3.029 | 12.33 |
Enterprise Value (EV) 1 | 3.17 | 2.731 | 5.336 | 3.631 | 4.238 | 12.7 |
P/E ratio | -24.2 x | -18.8 x | -31.6 x | 9.82 x | 39.2 x | 28 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.91 x | 1.27 x | 4.81 x | 1.84 x | 2.19 x | 3.7 x |
EV / Revenue | 4.23 x | 3.29 x | 6.72 x | 3.36 x | 3.07 x | 3.81 x |
EV / EBITDA | 22.9 x | 19.3 x | 661 x | 11.2 x | 13.9 x | 16.9 x |
EV / FCF | 32.9 x | 21.9 x | 56.1 x | 536 x | 10.5 x | 28.9 x |
FCF Yield | 3.04% | 4.57% | 1.78% | 0.19% | 9.57% | 3.47% |
Price to Book | -1.22 x | -0.88 x | -2.92 x | -1.85 x | -3.2 x | 80.2 x |
Nbr of stocks (in thousands) | 31,430 | 31,430 | 31,430 | 31,804 | 31,804 | 44,054 |
Reference price 2 | 0.0455 | 0.0336 | 0.1216 | 0.0624 | 0.0953 | 0.2800 |
Announcement Date | 6/28/19 | 6/29/20 | 6/28/21 | 6/28/22 | 6/28/23 | 6/27/24 |
Income Statement Evolution (Annual data)
Fiscal Period: February | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales 1 | 0.7498 | 0.8311 | 0.7946 | 1.082 | 1.382 | 3.337 |
EBITDA 1 | 0.1384 | 0.1411 | 0.008073 | 0.3228 | 0.3038 | 0.753 |
EBIT 1 | 0.0124 | 0.013 | -0.1218 | 0.21 | 0.1893 | 0.6353 |
Operating Margin | 1.65% | 1.56% | -15.33% | 19.42% | 13.7% | 19.03% |
Earnings before Tax (EBT) 1 | -0.0584 | -0.0585 | -0.121 | 0.2006 | 0.0838 | 0.3817 |
Net income 1 | -0.0592 | -0.0561 | -0.121 | 0.2006 | 0.0798 | 0.3817 |
Net margin | -7.89% | -6.75% | -15.22% | 18.55% | 5.77% | 11.44% |
EPS 2 | -0.001882 | -0.001784 | -0.003848 | 0.006357 | 0.002433 | 0.0100 |
Free Cash Flow 1 | 0.0964 | 0.1248 | 0.0952 | 0.006773 | 0.4055 | 0.4401 |
FCF margin | 12.86% | 15.01% | 11.98% | 0.63% | 29.35% | 13.19% |
FCF Conversion (EBITDA) | 69.67% | 88.42% | 1,178.64% | 2.1% | 133.47% | 58.45% |
FCF Conversion (Net income) | - | - | - | 3.38% | 508.42% | 115.32% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 6/28/19 | 6/29/20 | 6/28/21 | 6/28/22 | 6/28/23 | 6/27/24 |
Balance Sheet Analysis
Fiscal Period: February | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.74 | 1.68 | 1.51 | 1.65 | 1.21 | 0.37 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 12.56 x | 11.87 x | 187.6 x | 5.098 x | 3.978 x | 0.4855 x |
Free Cash Flow 1 | 0.1 | 0.12 | 0.1 | 0.01 | 0.41 | 0.44 |
ROE (net income / shareholders' equity) | 5.15% | 4.73% | 9.65% | -16.8% | -7.9% | -95.3% |
ROA (Net income/ Total Assets) | 0.92% | 1.14% | -13.7% | 18.4% | 11.9% | 23.4% |
Assets 1 | -6.402 | -4.901 | 0.8804 | 1.088 | 0.6729 | 1.632 |
Book Value Per Share 2 | -0.0400 | -0.0400 | -0.0400 | -0.0300 | -0.0300 | 0 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0.0100 | 0.0200 |
Capex 1 | 0.02 | - | - | 0.01 | 0.09 | 0.01 |
Capex / Sales | 2.73% | - | - | 0.71% | 6.21% | 0.43% |
Announcement Date | 6/28/19 | 6/29/20 | 6/28/21 | 6/28/22 | 6/28/23 | 6/27/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+15.82% | 89.02B | |
+16.76% | 69.14B | |
+25.77% | 39.25B | |
+21.04% | 33.56B | |
+7.11% | 26.61B | |
+2.66% | 26.61B | |
+0.55% | 26.12B | |
+19.97% | 25.36B | |
+2.36% | 22.36B |
- Stock Market
- Equities
- CNO Stock
- CANOF Stock
- Financials California Nanotechnologies Corp.